Serum copper, ceruloplasmin and thiobarbituric acid reactive substance status in patients with ovarian cancer

Indian Journal of Physiology and Pharmacology

Volumn 48, Issue 4, 2004, Pages 486-488

  Nayak, Shivananda B ^a   Bhat, Vinutha R ^a   Mayya, Srimathi S ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

CA 125; Ceruloplasmin; Copper; Ovarian cancer; Substance; Thiobarbituric acid reactive

Indexed keywords

CA 125 ANTIGEN; CERULOPLASMIN; COPPER; FREE RADICAL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRACE ELEMENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CARCINOGENESIS; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; COPPER BLOOD LEVEL; FEMALE; HUMAN; LIPID PEROXIDATION; OVARY CANCER;

ADULT; AGED; CA-125 ANTIGEN; CERULOPLASMIN; COPPER; FEMALE; HUMANS; LIPID PEROXIDATION; MIDDLE AGED; OVARIAN NEOPLASMS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 6344287103     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Brandes JM, Lightman A, Drugau A, Zinder D, Cohen A, Itskovtig J. The Diagnostic value of serum copper/zinc ratio in gynecological tumors. Acta Obstet Gynecol Scand 1983; 62: 225-229.
2. Thakur V, Anand AK, Mukerjee U, Ghosh D. Determination of cancer antigen 125 in ovarian cancer. Indian J Clin Biochem 2003; 18: 27-33.
3. Aryumanayagam M, Wang FW, Rogers M, Swaminathan R. Serum ceruloplasmin, plasma copper concentration and copper to ceruloplasmin ratio in cervical cancer. Gynaec Obst Invest 1993; 35: 175-178.
4. Induced Oxidative stress in intestinal mucosa. Mol Cell Biochem 1998; 189: 113-118.
5. Zak B, Landevs JW. Copper in serum. J Clin Clin Pathol 1958; 29: 590-292.
6. Ravan HA. Copper oxidase activity. J Lab Clin Med 1961; 58: 161-163.
7. Wayne PA. National Committee for Clinical laboratory standards. Approved guidelines NCCLS Procurement 1/LA 19A: NCCLS: 1997.
8. Gutteridge JMC, Tickner TR. Biochem Med 1978; 19: 127-132.
9. Nayak BS, Bhat VR, Upadhya D, Udupa SL, Copper and ceruloplasmin status inn serum of prostate and colon cancer. Indian J Physiol Pharmacol 2003; 47: 108-110.
10. Steward AM, Niren D. Carcinoembryonic antigen in breast cancer patients. Cancer 1974; 33: 1246-1247.
11. Concanon JP, Dawbow MH. Prognostic value of preoperative carcinoma. Cancer 1978; 142: 1477-1479.
12. Joshi PC. Copper (II) as an efficient scavenger of singlet molecular oxygen. Ind J Biochem Biophys 1998; 35: 208-215.
13. Lightman A, Brandes JM, Binur N, Drugan A, Zinder O. Use of the serum copper/zinc ratio in the differential diagnosis of ovarian malignancy. Clin Chem 1986; 32: 1788-1792.
14. Gutteridge JMC, Tickner TR. The characterization of thiobarbituric acid reactivity in human plasma and urine. Anal Biochem 1978; 91: 250-257.
15. Rajput BS, Gupta SN, Sur KN, Pandey RP, Singh S. Evaluation of serum copper levels in diagnosis and prognosis of various malignancies. Ind J Surgery 1979; 41: 375-379.